Lankisch et al.23 revealed that serum Cystatin C was an alternative to serum creatinine for monitoring kidney functions and GFR in pediatric cancer patients with solid tumors and hematological malignancies as it is less dependent on influential factors like weight, height, and muscle mass. The gene discussed is CST3; the disease is hematologic disorder.